Published in J Am Chem Soc on July 27, 2005
Glycotherapy: new advances inspire a reemergence of glycans in medicine. Chem Biol (2013) 1.04
Glycopolymer probes of signal transduction. Chem Soc Rev (2013) 0.98
Immunosuppressive and anti-inflammatory properties of engineered nanomaterials. Br J Pharmacol (2014) 0.90
Anti-inflammatory polymeric coatings for implantable biomaterials and devices. J Diabetes Sci Technol (2008) 0.87
Hyaluronan-based Glycoclusters as Probes for Chemical Glycobiology. Tetrahedron Lett (2007) 0.83
Short-term and long-term effects of orthopedic biodegradable implants. J Long Term Eff Med Implants (2011) 0.83
Janus-type dendrimer-like poly(ethylene oxide)s. J Am Chem Soc (2008) 0.80
Designing polymers with sugar-based advantages for bioactive delivery applications. J Control Release (2015) 0.77
Glycomaterials for probing host-pathogen interactions and the immune response. Exp Biol Med (Maywood) (2016) 0.76
Pro-Inflammatory Versus Anti-Inflammatory Effects of Dendrimers: The Two Faces of Immuno-Modulatory Nanoparticles. Nanomaterials (Basel) (2017) 0.75
The cluster glycoside effect. Chem Rev (2002) 2.79
The role of selectins in inflammation and disease. Trends Mol Med (2003) 2.44
Heparin's anti-inflammatory effects require glucosamine 6-O-sulfation and are mediated by blockade of L- and P-selectins. J Clin Invest (2002) 1.91
Leukocyte and endothelial cell adhesion molecules as targets for therapeutic interventions in inflammatory disease. Trends Pharmacol Sci (2003) 1.65
Endothelial ligands for L-selectin: from lymphocyte recirculation to allograft rejection. Am J Pathol (1999) 1.39
Polyvalent dendrimer glucosamine conjugates prevent scar tissue formation. Nat Biotechnol (2004) 1.26
Inhibition of viral adhesion and infection by sialic-acid-conjugated dendritic polymers. Bioconjug Chem (1999) 1.15
Dendritic polyglycerol: a new versatile biocompatible-material. J Biotechnol (2002) 1.05
Synthetic glycoprotein mimics inhibit L-selectin-mediated rolling and promote L-selectin shedding. Chem Biol (2004) 1.00
Peptido- and glycocalixarenes: playing with hydrogen bonds around hydrophobic cavities. Acc Chem Res (2003) 0.96
Carbohydrates in an acidic multivalent assembly: nanomolar P-selectin inhibitors. J Med Chem (1996) 0.96
Inhibition of L-selectin-mediated leukocyte rolling by synthetic glycoprotein mimics. J Biol Chem (1999) 0.96
Therapeutic inhibition of carbohydrate-protein interactions in vivo. J Clin Invest (1997) 0.96
Minimal sulfated carbohydrates for recognition by L-selectin and the MECA-79 antibody. J Biol Chem (2000) 0.93
L-selectin interactions with novel mono- and multisulfated Lewisx sequences in comparison with the potent ligand 3'-sulfated Lewisa. J Biol Chem (1999) 0.92
Inhibition of selectin-mediated cell adhesion and prevention of acute inflammation by nonanticoagulant sulfated saccharides. Studies with carboxyl-reduced and sulfated heparin and with trestatin a sulfate. J Biol Chem (2000) 0.90
Selectin-blocking semisynthetic sulfated polysaccharides as promising anti-inflammatory agents. J Pharm Pharmacol (2003) 0.86
Nanomolar E-selectin inhibitors: 700-fold potentiation of affinity by multivalent ligand presentation. J Am Chem Soc (2001) 0.86
Macrocyclic glycoclusters: from amphiphiles through nanoparticles to glycoviruses. Chemistry (2004) 0.80
Heparan sulphate proteoglycans fine-tune mammalian physiology. Nature (2007) 7.87
A myocardial lineage derives from Tbx18 epicardial cells. Nature (2008) 6.15
The sweet and sour of cancer: glycans as novel therapeutic targets. Nat Rev Cancer (2005) 5.98
Endothelial heparan sulfate deficiency impairs L-selectin- and chemokine-mediated neutrophil trafficking during inflammatory responses. Nat Immunol (2005) 3.82
Loss of HIF-1alpha in endothelial cells disrupts a hypoxia-driven VEGF autocrine loop necessary for tumorigenesis. Cancer Cell (2004) 3.28
Adult mouse epicardium modulates myocardial injury by secreting paracrine factors. J Clin Invest (2011) 2.99
Heparan sulfate proteoglycans. Cold Spring Harb Perspect Biol (2011) 2.96
Heparan sulfate proteoglycans provide a signal to Plasmodium sporozoites to stop migrating and productively invade host cells. Cell Host Microbe (2007) 2.64
Liver heparan sulfate proteoglycans mediate clearance of triglyceride-rich lipoproteins independently of LDL receptor family members. J Clin Invest (2007) 2.53
Heparin's anti-inflammatory effects require glucosamine 6-O-sulfation and are mediated by blockade of L- and P-selectins. J Clin Invest (2002) 1.91
Evolutionary differences in glycosaminoglycan fine structure detected by quantitative glycan reductive isotope labeling. J Biol Chem (2008) 1.91
A prospectively validated clinical risk score accurately predicts pancreatic fistula after pancreatoduodenectomy. J Am Coll Surg (2012) 1.89
2009 ACCF/AHA focused update on perioperative beta blockade incorporated into the ACC/AHA 2007 guidelines on perioperative cardiovascular evaluation and care for noncardiac surgery. J Am Coll Cardiol (2009) 1.86
Mice deficient in Ext2 lack heparan sulfate and develop exostoses. Development (2005) 1.84
Disaccharide structure code for the easy representation of constituent oligosaccharides from glycosaminoglycans. Nat Methods (2008) 1.84
Pathogen-sensing plasmacytoid dendritic cells stimulate cytotoxic T-cell function in the atherosclerotic plaque through interferon-alpha. Circulation (2006) 1.77
Demystifying heparan sulfate-protein interactions. Annu Rev Biochem (2014) 1.76
Abnormal patterns of lipoprotein lipase release into the plasma in GPIHBP1-deficient mice. J Biol Chem (2008) 1.73
Caenorhabditis elegans early embryogenesis and vulval morphogenesis require chondroitin biosynthesis. Nature (2003) 1.73
Cerebral hypoplasia and craniofacial defects in mice lacking heparan sulfate Ndst1 gene function. Development (2005) 1.69
Prolonged administration of doxycycline in patients with small asymptomatic abdominal aortic aneurysms: report of a prospective (Phase II) multicenter study. J Vasc Surg (2002) 1.64
Accuracy of administrative data versus clinical data to evaluate carotid endarterectomy and carotid stenting. J Vasc Surg (2013) 1.59
Coating optimization of superparamagnetic iron oxide nanoparticles for high T2 relaxivity. Nano Lett (2010) 1.58
Reporting standards for thoracic endovascular aortic repair (TEVAR). J Vasc Surg (2010) 1.56
Syndecan-1 is the primary heparan sulfate proteoglycan mediating hepatic clearance of triglyceride-rich lipoproteins in mice. J Clin Invest (2009) 1.56
Symbol nomenclature for glycan representation. Proteomics (2009) 1.56
Delayed targeting of CD39 to activated platelet GPIIb/IIIa via a single-chain antibody: breaking the link between antithrombotic potency and bleeding? Blood (2013) 1.54
Heparan sulfate and syndecan-1 are essential in maintaining murine and human intestinal epithelial barrier function. J Clin Invest (2008) 1.52
Carbohydrate and protein immobilization onto solid surfaces by sequential Diels-Alder and azide-alkyne cycloadditions. Bioconjug Chem (2006) 1.51
A focused microarray approach to functional glycomics: transcriptional regulation of the glycome. Glycobiology (2005) 1.49
Synergistic proinflammatory effects of the antiviral cytokine interferon-alpha and Toll-like receptor 4 ligands in the atherosclerotic plaque. Circulation (2007) 1.47
Surgical management of descending thoracic aortic disease: open and endovascular approaches: a scientific statement from the American Heart Association. Circulation (2010) 1.47
Heparan sulfate biosynthetic gene Ndst1 is required for FGF signaling in early lens development. Development (2006) 1.46
An activation-specific platelet inhibitor that can be turned on/off by medically used hypothermia. Arterioscler Thromb Vasc Biol (2011) 1.46
The impact of endovascular procedures on fellowship training in lower extremity revascularization. J Vasc Surg (2012) 1.44
Disease-specific non-reducing end carbohydrate biomarkers for mucopolysaccharidoses. Nat Chem Biol (2012) 1.43
Resistance to a bacterial toxin is mediated by removal of a conserved glycosylation pathway required for toxin-host interactions. J Biol Chem (2003) 1.41
A dumbbell-shaped small molecule that promotes cell adhesion and growth. Chem Biol (2009) 1.39
Repulsive axon guidance molecule Slit3 is a novel angiogenic factor. Blood (2009) 1.37
Genetic alteration of endothelial heparan sulfate selectively inhibits tumor angiogenesis. J Cell Biol (2007) 1.36
Cellular heparan sulfate participates in the metabolism of prions. J Biol Chem (2003) 1.34
Heparan sulfate and development: differential roles of the N-acetylglucosamine N-deacetylase/N-sulfotransferase isozymes. Biochim Biophys Acta (2002) 1.34
Viscoelastic and mechanical behavior of recombinant protein elastomers. Biomaterials (2005) 1.31
Identification of novel chondroitin proteoglycans in Caenorhabditis elegans: embryonic cell division depends on CPG-1 and CPG-2. J Cell Biol (2006) 1.29
Bud specific N-sulfation of heparan sulfate regulates Shp2-dependent FGF signaling during lacrimal gland induction. Development (2007) 1.27
Surfen, a small molecule antagonist of heparan sulfate. Proc Natl Acad Sci U S A (2008) 1.26
The effect of a recombinant elastin-mimetic coating of an ePTFE prosthesis on acute thrombogenicity in a baboon arteriovenous shunt. Biomaterials (2006) 1.24
D-periodic collagen-mimetic microfibers. J Am Chem Soc (2007) 1.24
Challenges and emerging technologies in the immunoisolation of cells and tissues. Adv Drug Deliv Rev (2007) 1.24
Essential alterations of heparan sulfate during the differentiation of embryonic stem cells to Sox1-enhanced green fluorescent protein-expressing neural progenitor cells. Stem Cells (2007) 1.23
Contribution of proteoglycans to human immunodeficiency virus type 1 brain invasion. J Virol (2004) 1.23
Self-assembly of phospholipid-PEG coating on nanoparticles through dual solvent exchange. Nano Lett (2011) 1.23
Functional UDP-xylose transport across the endoplasmic reticulum/Golgi membrane in a Chinese hamster ovary cell mutant defective in UDP-xylose Synthase. J Biol Chem (2008) 1.23
Micelle density regulated by a reversible switch of protein secondary structure. J Am Chem Soc (2006) 1.21
Water-soluble stimuli-responsive vesicles from peptide-based diblock copolymers. Angew Chem Int Ed Engl (2002) 1.20
Biomaterials for vascular tissue engineering. Regen Med (2010) 1.19
Lacrimal gland development and Fgf10-Fgfr2b signaling are controlled by 2-O- and 6-O-sulfated heparan sulfate. J Biol Chem (2011) 1.19
Variant heparan sulfates synthesized in developing mouse brain differentially regulate FGF signaling. Glycobiology (2002) 1.18
A prospective evaluation of hypogastric artery embolization in endovascular aortoiliac aneurysm repair. J Vasc Surg (2002) 1.16
A disaccharide precursor of sialyl Lewis X inhibits metastatic potential of tumor cells. Cancer Res (2003) 1.16
Alterations in physical cross-linking modulate mechanical properties of two-phase protein polymer networks. Biomacromolecules (2005) 1.16
Elastin-mimetic protein polymers capable of physical and chemical crosslinking. Biomaterials (2008) 1.15
Hereditary multiple exostoses and heparan sulfate polymerization. Biochim Biophys Acta (2002) 1.15
Layer-by-layer assembly of a conformal nanothin PEG coating for intraportal islet transplantation. Nano Lett (2008) 1.14
Heparan sulfate 2-O-sulfotransferase is required for triglyceride-rich lipoprotein clearance. J Biol Chem (2009) 1.13
Covered stent exclusion of dialysis access pseudoaneurysms. J Surg Res (2002) 1.10
Novel thromboresistant materials. J Vasc Surg (2007) 1.10
Photo-cross-linking of type I collagen gels in the presence of smooth muscle cells: mechanical properties, cell viability, and function. Biomacromolecules (2003) 1.09
Tumor attenuation by combined heparan sulfate and polyamine depletion. Proc Natl Acad Sci U S A (2001) 1.09
Heparan sulfate is required for embryonic stem cells to exit from self-renewal. J Biol Chem (2009) 1.09
Heparan 2-O-sulfotransferase, hst-2, is essential for normal cell migration in Caenorhabditis elegans. Proc Natl Acad Sci U S A (2005) 1.09
Metabolic engineering of Chinese hamster ovary cells: towards a bioengineered heparin. Metab Eng (2012) 1.09
The Caenorhabditis elegans genes sqv-2 and sqv-6, which are required for vulval morphogenesis, encode glycosaminoglycan galactosyltransferase II and xylosyltransferase. J Biol Chem (2003) 1.08
Regulated translation of heparan sulfate N-acetylglucosamine N-deacetylase/n-sulfotransferase isozymes by structured 5'-untranslated regions and internal ribosome entry sites. J Biol Chem (2002) 1.07
Guanidinylated neomycin delivers large, bioactive cargo into cells through a heparan sulfate-dependent pathway. J Biol Chem (2007) 1.07
Deformation responses of a physically cross-linked high molecular weight elastin-like protein polymer. Biomacromolecules (2008) 1.07
Stable RAGE-heparan sulfate complexes are essential for signal transduction. ACS Chem Biol (2013) 1.07
Elastin-like protein matrix reinforced with collagen microfibers for soft tissue repair. Biomaterials (2011) 1.06
Glycosaminoglycan mimetic biomaterials. 4. Synthesis of sulfated lactose-based glycopolymers that exhibit anticoagulant activity. Biomacromolecules (2002) 1.06
Self-assembly of thermally responsive amphiphilic diblock copolypeptides into spherical micellar nanoparticles. Angew Chem Int Ed Engl (2010) 1.06
CHO glycosylation mutants: proteoglycans. Methods Enzymol (2006) 1.06
C-terminal site-specific PEGylation of a truncated thrombomodulin mutant with retention of full bioactivity. Bioconjug Chem (2004) 1.05
Regulation of ureteric bud branching morphogenesis by sulfated proteoglycans in the developing kidney. Dev Biol (2004) 1.05
Glycan antagonists and inhibitors: a fount for drug discovery. Crit Rev Biochem Mol Biol (2007) 1.05
Cell surface heparan sulfate is a receptor for attachment of envelope protein-free retrovirus-like particles and VSV-G pseudotyped MLV-derived retrovirus vectors to target cells. Mol Ther (2002) 1.05
The use of microfiber composites of elastin-like protein matrix reinforced with synthetic collagen in the design of vascular grafts. Biomaterials (2010) 1.05